Literature DB >> 2613338

Incidence of strains producing extended spectrum beta-lactamases in Argentina.

J M Casellas1, M Goldberg.   

Abstract

The incidence of strains producing transferable beta-lactamases capable of hydrolyzing third generation cephalosporins or aminothiazole-oximino substituted monobactams in five Buenos Aires hospitals during a four month period was studied. These enzymes were categorized by 1) MIC greater than or equal to 1 mg/l for third generation cephalosporins; 2) MIC less than 0.06 mg/l for third generation cephalosporins combined with clavulanic acid or sulbactam; 3) sensitivity to imipenem or cephamycins (excluding permeability mutants); and 4) transferable resistance by conjugation. Beta-lactamases hydrolyzing aminothiazole-oximino substituted monobactams were produced by 17.2% of Enterobacteriaceae from intensive care unit patients; 3.6% from inpatients of other units and 1.2% from outpatients. Producers were mainly Klebsiella spp. (45/46) resistant to aminoglycosides (most of them AAC 3'-AAC 6' producers). Three strains had a an isoelectric point of 6.0, two of 6.5 and three of 7.7. TEM-1 beta-lactamase (isoelectric point 5.4) was detected in 6/8 strains. An inocolum effect was observed in 40/46 strains. A Klebsiella pneumoniae strain preserved since 1982 also produced a transferable beta-lactamase hydrolyzing aminothiazole-oximino substituted monobactams.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613338     DOI: 10.1007/bf01645567

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  [Genetic map and structure in "Escherichia coli" K12 of a resistance plasmid isolated from "Salmonella ordonez" (author's transl)].

Authors:  D D Lesage; G R Gerbaud; Y A Chabbert
Journal:  Ann Microbiol (Paris)       Date:  1975 May-Jun

2.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

3.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  [Statement of the Antibiogram Committee of the French Microbiological Society].

Authors: 
Journal:  Pathol Biol (Paris)       Date:  1985-05
  4 in total
  14 in total

1.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests.

Authors:  K S Thomson; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 5.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

6.  Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find.

Authors:  P E Coudron; E S Moland; C C Sanders
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center.

Authors:  C L Emery; L A Weymouth
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

8.  Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Authors:  K S Thomson; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

9.  Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?

Authors:  E S Moland; C C Sanders; K S Thomson
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

Authors:  A Bauernfeind; Y Chong; S Schweighart
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.